» Articles » PMID: 34741931

Moving Ru Polypyridyl Complexes Beyond Cytotoxic Activity Towards Metastasis Inhibition

Overview
Journal J Inorg Biochem
Specialty Biochemistry
Date 2021 Nov 6
PMID 34741931
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

In recent years, Ru polypyridyl complexes have been intensively studied for their anticancer activity. The vast majority of research focuses on assessing their cytotoxic activity, as well as targeting cancer cells with them. Since the formation of metastases poses a greater risk than primary tumors, scientists recently began evaluating these compounds as potential metastasis inhibitors. This review highlights the latest achievements in this field with particular attention to the identification of the target proteins responsible for such activity. Cell migration, invasion, and adhesion are key components of metastasis, therefore understanding how they are affected by Ru polypyridyl complexes is of great importance. KEYWORDS: Ruthenium polypyridyl complexes Antimetastatic Migration Invasion Adhesion Metalloproteinases.

Citing Articles

Interactions of ruthenium(II) polypyridyl complexes with human telomeric DNA.

Tran V, Turek-Herman J, Ferreira M, Martin K, Beseiso D, Williams B J Inorg Biochem. 2023; 249:112388.

PMID: 37837940 PMC: 10668861. DOI: 10.1016/j.jinorgbio.2023.112388.


Ir(III) Compounds Containing a Terdentate Ligand Are Potent Inhibitors of Proliferation and Effective Antimetastatic Agents in Aggressive Triple-Negative Breast Cancer Cells.

Novohradsky V, Marco A, Markova L, Cutillas N, Ruiz J, Brabec V J Med Chem. 2023; 66(14):9766-9783.

PMID: 37410386 PMC: 10388354. DOI: 10.1021/acs.jmedchem.3c00586.


Anticancer Activity and Mode of Action of Cu(II), Zn(II), and Mn(II) Complexes with 5-Chloro-2--(2-quinolylmethylene)aminophenol.

Gai S, He L, He M, Zhong X, Jiang C, Qin Y Molecules. 2023; 28(12).

PMID: 37375431 PMC: 10300901. DOI: 10.3390/molecules28124876.


Low-Temperature Observation of the Excited-State Decay of Ruthenium-(Mono-2,2':6',2″-Terpyridine) Ions with Innocent Ligands: DFT Modeling of an MLCT-MC Intersystem Crossing Pathway.

Yin C, Tsai M, Chen Y ACS Omega. 2023; 8(12):11623-11633.

PMID: 37008138 PMC: 10061511. DOI: 10.1021/acsomega.3c01006.


Molecular Design, Spectroscopic, DFT, Pharmacological, and Molecular Docking Studies of Novel Ruthenium(III)-Schiff Base Complex: An Inhibitor of Progression in HepG2 Cells.

Noureldeen A, Aziz S, Shouman S, Mohamed M, Attia Y, Ramadan R Int J Environ Res Public Health. 2022; 19(20).

PMID: 36294202 PMC: 9603487. DOI: 10.3390/ijerph192013624.